List of Tables

Table 1. Metabolic Disease Therapeutics Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Metabolic Disease Therapeutics Market Restraints

Table 3. Metabolic Disease Therapeutics Market Trends

Table 4. Metabolic Disease Therapeutics Industry Policy

Table 5. Global Metabolic Disease Therapeutics Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Metabolic Disease Therapeutics Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Metabolic Disease Therapeutics Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Metabolic Disease Therapeutics Mergers & Acquisitions, Expansion Plans

Table 9. Global Metabolic Disease Therapeutics Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Metabolic Disease Therapeutics Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 12. China Metabolic Disease Therapeutics Revenue Market Share by Company, 2020-2025

Table 13. Global Key Players of Metabolic Disease Therapeutics Upstream (Raw Materials)

Table 14. Global Metabolic Disease Therapeutics Typical Customers

Table 15. Metabolic Disease Therapeutics Typical Distributors

Table 16. by Type, Global Metabolic Disease Therapeutics Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 17. by Application, Global Metabolic Disease Therapeutics Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 18. By Region, Global Metabolic Disease Therapeutics Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 19. By Region, Global Metabolic Disease Therapeutics Consumption Value, 2020-2031, US$ Million

Table 20. By Country, Global Metabolic Disease Therapeutics Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 21. By Country, Global Metabolic Disease Therapeutics Consumption Value, 2020-2031, US$ Million

Table 22. By Country, Global Metabolic Disease Therapeutics Consumption Value Market Share, 2020-2031

Table 23. Merck Company Information, Head Office, Market Area, and Industry Position

Table 24. Merck Company Profile and Main Business

Table 25. Merck Metabolic Disease Therapeutics Models, Specifications, and Application

Table 26. Merck Metabolic Disease Therapeutics Revenue and Gross Margin, US$ Million, 2020-2025

Table 27. Merck Recent Developments

Table 28. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 29. Novartis Company Profile and Main Business

Table 30. Novartis Metabolic Disease Therapeutics Models, Specifications, and Application

Table 31. Novartis Metabolic Disease Therapeutics Revenue and Gross Margin, US$ Million, 2020-2025

Table 32. Novartis Recent Developments

Table 33. Takeda Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 34. Takeda Pharmaceutical Company Profile and Main Business

Table 35. Takeda Pharmaceutical Metabolic Disease Therapeutics Models, Specifications, and Application

Table 36. Takeda Pharmaceutical Metabolic Disease Therapeutics Revenue and Gross Margin, US$ Million, 2020-2025

Table 37. Takeda Pharmaceutical Recent Developments

Table 38. Astra Zeneca Company Information, Head Office, Market Area, and Industry Position

Table 39. Astra Zeneca Company Profile and Main Business

Table 40. Astra Zeneca Metabolic Disease Therapeutics Models, Specifications, and Application

Table 41. Astra Zeneca Metabolic Disease Therapeutics Revenue and Gross Margin, US$ Million, 2020-2025

Table 42. Astra Zeneca Recent Developments

Table 43. Beohrigher Ingelheim Company Information, Head Office, Market Area, and Industry Position

Table 44. Beohrigher Ingelheim Company Profile and Main Business

Table 45. Beohrigher Ingelheim Metabolic Disease Therapeutics Models, Specifications, and Application

Table 46. Beohrigher Ingelheim Metabolic Disease Therapeutics Revenue and Gross Margin, US$ Million, 2020-2025

Table 47. Beohrigher Ingelheim Recent Developments

Table 48. KOWA Company Information, Head Office, Market Area, and Industry Position

Table 49. KOWA Company Profile and Main Business

Table 50. KOWA Metabolic Disease Therapeutics Models, Specifications, and Application

Table 51. KOWA Metabolic Disease Therapeutics Revenue and Gross Margin, US$ Million, 2020-2025

Table 52. KOWA Recent Developments

Table 53. Kythera Company Information, Head Office, Market Area, and Industry Position

Table 54. Kythera Company Profile and Main Business

Table 55. Kythera Metabolic Disease Therapeutics Models, Specifications, and Application

Table 56. Kythera Metabolic Disease Therapeutics Revenue and Gross Margin, US$ Million, 2020-2025

Table 57. Kythera Recent Developments

Table 58. Fuji yakuhin Company Information, Head Office, Market Area, and Industry Position

Table 59. Fuji yakuhin Company Profile and Main Business

Table 60. Fuji yakuhin Metabolic Disease Therapeutics Models, Specifications, and Application

Table 61. Fuji yakuhin Metabolic Disease Therapeutics Revenue and Gross Margin, US$ Million, 2020-2025

Table 62. Fuji yakuhin Recent Developments

Table 63. LG Life Science Company Information, Head Office, Market Area, and Industry Position

Table 64. LG Life Science Company Profile and Main Business

Table 65. LG Life Science Metabolic Disease Therapeutics Models, Specifications, and Application

Table 66. LG Life Science Metabolic Disease Therapeutics Revenue and Gross Margin, US$ Million, 2020-2025

Table 67. LG Life Science Recent Developments

Table 68. Metsubishi Tanabe Pharma Company Information, Head Office, Market Area, and Industry Position

Table 69. Metsubishi Tanabe Pharma Company Profile and Main Business

Table 70. Metsubishi Tanabe Pharma Metabolic Disease Therapeutics Models, Specifications, and Application

Table 71. Metsubishi Tanabe Pharma Metabolic Disease Therapeutics Revenue and Gross Margin, US$ Million, 2020-2025

Table 72. Metsubishi Tanabe Pharma Recent Developments

List of Figures

Figure 1. Metabolic Disease Therapeutics Picture

Figure 2. Global Metabolic Disease Therapeutics Consumption Value, (US$ million) & (2020-2031)

Figure 3. China Metabolic Disease Therapeutics Consumption Value, (US$ million) & (2020-2031)

Figure 4. By Consumption Value, China Metabolic Disease Therapeutics Market Share of Global, 2020-2031

Figure 5. Global Metabolic Disease Therapeutics Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 6. China Metabolic Disease Therapeutics Key Participants, Market Share, 2024

Figure 7. Metabolic Disease Therapeutics Industry Chain

Figure 8. Metabolic Disease Therapeutics Procurement Model

Figure 9. Metabolic Disease Therapeutics Sales Model

Figure 10. Metabolic Disease Therapeutics Sales Channels, Direct Sales, and Distribution

Figure 11. Glycogen Metabolism Disease Drug

Figure 12. Lipid Metabolism Disease Drug

Figure 13. Amino Acid Metabolism Drug

Figure 14. Other

Figure 15. by Type, Global Metabolic Disease Therapeutics Consumption Value, 2020-2031, US$ Million

Figure 16. by Type, Global Metabolic Disease Therapeutics Consumption Value Market Share, 2020-2031

Figure 17. Hospital Pharmacy

Figure 18. Retail Pharmacy

Figure 19. by Application, Global Metabolic Disease Therapeutics Consumption Value, 2020-2031, US$ Million

Figure 20. by Application, Global Metabolic Disease Therapeutics Revenue Market Share, 2020-2031

Figure 21. By Region, Global Metabolic Disease Therapeutics Consumption Value Market Share, 2020-2031

Figure 22. North America Metabolic Disease Therapeutics Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 23. By Country, North America Metabolic Disease Therapeutics Consumption Value Market Share, 2024

Figure 24. Europe Metabolic Disease Therapeutics Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 25. By Country, Europe Metabolic Disease Therapeutics Consumption Value Market Share, 2024

Figure 26. Asia Pacific Metabolic Disease Therapeutics Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 27. By Country/Region, Asia Pacific Metabolic Disease Therapeutics Consumption Value Market Share, 2024

Figure 28. South America Metabolic Disease Therapeutics Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 29. By Country, South America Metabolic Disease Therapeutics Consumption Value Market Share, 2024

Figure 30. Middle East & Africa Metabolic Disease Therapeutics Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 31. United States Metabolic Disease Therapeutics Consumption Value, 2020-2031, US$ Million

Figure 32. by Type, United States Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 33. by Application, United States Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 34. Europe Metabolic Disease Therapeutics Consumption Value, 2020-2031, US$ Million

Figure 35. by Type, Europe Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 36. by Application, Europe Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 37. China Metabolic Disease Therapeutics Consumption Value, 2020-2031, US$ Million

Figure 38. by Type, China Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 39. by Application, China Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 40. Japan Metabolic Disease Therapeutics Consumption Value, 2020-2031, US$ Million

Figure 41. by Type, Japan Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 42. by Application, Japan Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 43. South Korea Metabolic Disease Therapeutics Consumption Value, 2020-2031, US$ Million

Figure 44. by Type, South Korea Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 45. by Application, South Korea Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 46. Southeast Asia Metabolic Disease Therapeutics Consumption Value, 2020-2031, US$ Million

Figure 47. by Type, Southeast Asia Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 48. by Application, Southeast Asia Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 49. India Metabolic Disease Therapeutics Consumption Value, 2020-2031, US$ Million

Figure 50. by Type, India Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 51. by Application, India Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 52. Middle East & Africa Metabolic Disease Therapeutics Consumption Value, 2020-2031, US$ Million

Figure 53. by Type, Middle East & Africa Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 54. by Application, Middle East & Africa Metabolic Disease Therapeutics Consumption Value Market Share, 2024 VS 2031

Figure 55. Research Methodology

Figure 56. Breakdown of Primary Interviews

Figure 57. Bottom-up Approaches

Figure 58. Top-down Approaches